Search by PDB author

Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Spike glycoprotein, ...
Authors:	Hu, Y, Xiong, Y.
Deposit date:	2022-08-07
Release date:	2022-08-31
Last modified:	2023-11-15
Method:	ELECTRON MICROSCOPY (3.2 Å)
Cite:	Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages. Signal Transduct Target Ther, 8, 2023

8D36

Crystal structure of SARS-CoV-2 fusion peptide in complex with neutralizing antibody COV44-62
Descriptor:	Neutralizing antibody COV44-62 heavy chain, Neutralizing antibody COV44-62 light chain, Spike protein S2 fusion peptide
Authors:	Yuan, M, Lee, C.C.D, Wilson, I.A.
Deposit date:	2022-05-31
Release date:	2022-07-27
Last modified:	2023-10-18
Method:	X-RAY DIFFRACTION (1.45 Å)
Cite:	Broadly neutralizing antibodies target the coronavirus fusion peptide. Science, 377, 2022

8DAO

Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV44-79
Descriptor:	COV44-79 heavy chain constant domain, COV44-79 heavy chain variable domain, COV44-79 light chain constant domain, ...
Authors:	Lin, T.H, Lee, C.C.D, Yuan, M, Wilson, I.A.
Deposit date:	2022-06-13
Release date:	2022-07-27
Last modified:	2023-10-18
Method:	X-RAY DIFFRACTION (2.8 Å)
Cite:	Broadly neutralizing antibodies target the coronavirus fusion peptide. Science, 377, 2022

8D6Z

Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV91-27
Descriptor:	Neutralizing antibody COV91-27 heavy chain, Neutralizing antibody COV91-27 light chain, Spike protein S2 fusion peptide
Authors:	Lee, C.C.D, Lin, T.H, Yuan, M, Wilson, I.A.
Deposit date:	2022-06-06
Release date:	2022-07-27
Last modified:	2023-10-18
Method:	X-RAY DIFFRACTION (2.3 Å)
Cite:	Broadly neutralizing antibodies target the coronavirus fusion peptide. Science, 377, 2022

8DTT

Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody COV93-03
Descriptor:	COV93-03 heavy chain, COV93-03 light chain, Spike protein S2' stem helix peptide
Authors:	Lee, C.C.D, Lin, T.H, Wilson, I.A.
Deposit date:	2022-07-26
Release date:	2022-11-23
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (1.75 Å)
Cite:	Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses. Cell Host Microbe, 31, 2023

8DTR

Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody COV30-14
Descriptor:	COV30-14 heavy chain, COV30-14 light chain, Spike protein S2' stem helix peptide
Authors:	Lee, C.C.D, Lin, T.H, Wilson, I.A.
Deposit date:	2022-07-26
Release date:	2022-11-23
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (1.5 Å)
Cite:	Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses. Cell Host Microbe, 31, 2023

8DTX

Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody COV89-22
Descriptor:	COV89-22 heavy chain, COV89-22 light chain, Spike protein S2' stem helix peptide
Authors:	Lin, T.H, Lee, C.C.D, Wilson, I.A.
Deposit date:	2022-07-26
Release date:	2022-11-23
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (1.6 Å)
Cite:	Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses. Cell Host Microbe, 31, 2023

1SKX

Structural Disorder in the Complex of Human PXR and the Macrolide Antibiotic Rifampicin
Descriptor:	Orphan nuclear receptor PXR, RIFAMPICIN
Authors:	Chrencik, J.E, Xue, Y, Orans, J.O, Redinbo, M.R.
Deposit date:	2004-03-05
Release date:	2005-03-08
Last modified:	2023-08-23
Method:	X-RAY DIFFRACTION (2.8 Å)
Cite:	Structural disorder in the complex of human pregnane x receptor and the macrolide antibiotic rifampicin Mol.Endocrinol., 19, 2005

2L2J

Solution NMR structure of the lower part of the R/G stem loop RNA
Descriptor:	RNA (42-MER)
Authors:	Oberstrass, F.F, Allain, F.H.-T, Stefl, R.
Deposit date:	2010-08-20
Release date:	2010-10-27
Last modified:	2011-07-13
Method:	SOLUTION NMR
Cite:	The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a Sequence-Specific Readout of the Minor Groove. Cell(Cambridge,Mass.), 143, 2010

5YVF

Crystal structure of BFA1
Descriptor:	BFA1
Authors:	Pu, H, Zhang, L, Duan, Z.K, Peng, L.W, Liu, L.
Deposit date:	2017-11-25
Release date:	2018-08-08
Last modified:	2024-03-27
Method:	X-RAY DIFFRACTION (2.804 Å)
Cite:	Nucleus-Encoded Protein BFA1 Promotes Efficient Assembly of the Chloroplast ATP Synthase Coupling Factor 1. Plant Cell, 30, 2018

5ULA

Crystal Structure of the First Bromodomain of Human BRD4 in Complex With Cyclic Vinylogous Amide Inhibitor MS402
Descriptor:	3-chloranyl-~{N}-(4-methoxyphenyl)-4-[(2-methyl-3-oxidanylidene-cyclopenten-1-yl)amino]benzamide, Bromodomain-containing protein 4
Authors:	Plotnikov, A.N, Joshua, j, Zhou, M.-M.
Deposit date:	2017-01-24
Release date:	2017-03-22
Last modified:	2024-03-06
Method:	X-RAY DIFFRACTION (1.5 Å)
Cite:	BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice. Proc. Natl. Acad. Sci. U.S.A., 114, 2017

5L21

Crystal structure of BoNT/A receptor binding domain in complex with VHH C2
Descriptor:	Botulinum neurotoxin type A, VHH-C2
Authors:	Yao, G, Jin, R.
Deposit date:	2016-07-29
Release date:	2017-08-09
Last modified:	2023-10-04
Method:	X-RAY DIFFRACTION (1.68 Å)
Cite:	A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding. Sci Rep, 7, 2017

2L2K

Solution NMR structure of the R/G STEM LOOP RNA-ADAR2 DSRBM2 Complex
Descriptor:	Adenosine deaminase, RNA (42-MER)
Authors:	Allain, F.H.-T, Oberstrass, F.C, Stefl, R.
Deposit date:	2010-08-20
Release date:	2010-10-27
Last modified:	2011-07-13
Method:	SOLUTION NMR
Cite:	The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a Sequence-Specific Readout of the Minor Groove. Cell(Cambridge,Mass.), 143, 2010

2L3J

The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific read out of the minor groove
Descriptor:	Double-stranded RNA-specific editase 1, RNA (71-MER)
Authors:	Stefl, R, Oberstrass, F.C, Allain, F.H.-T.
Deposit date:	2010-09-14
Release date:	2010-10-27
Last modified:	2011-07-13
Method:	SOLUTION NMR
Cite:	The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a Sequence-Specific Readout of the Minor Groove. Cell(Cambridge,Mass.), 143, 2010

2L3C

Solution structure of ADAR2 dsRBM1 bound to LSL RNA
Descriptor:	Double-stranded RNA-specific editase 1, RNA (34-MER)
Authors:	Allain, F, Stefl, R, Oberstrass, F.
Deposit date:	2010-09-12
Release date:	2010-10-27
Last modified:	2011-07-13
Method:	SOLUTION NMR
Cite:	The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a Sequence-Specific Readout of the Minor Groove. Cell(Cambridge,Mass.), 143, 2010

8DGV

Crystal structure of MERS-CoV spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC99.103 isolated from a vaccinated COVID-19 convalescent
Descriptor:	Antibody CC99.103 Fab heavy chain, Antibody CC99.103 Fab light chain, Spike protein S2'
Authors:	Liu, H, Wilson, I.A.
Deposit date:	2022-06-24
Release date:	2023-01-25
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (2.3 Å)
Cite:	Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity, 56, 2023

8DGW

Crystal structure of HCoV-HKU1 spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC95.108 isolated from a vaccinated COVID-19 convalescent
Descriptor:	Antibody CC95.108 Fab heavy chain, Antibody CC95.108 Fab light chain, Spike protein S2'
Authors:	Liu, H, Wilson, I.A.
Deposit date:	2022-06-24
Release date:	2023-01-25
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (2.81 Å)
Cite:	Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity, 56, 2023

8DGU

Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC25.106 isolated from a vaccinated COVID-19 convalescent
Descriptor:	Antibody CC25.106 Fab heavy chain, Antibody CC25.106 Fab light chain, GLYCEROL, ...
Authors:	Liu, H, Wilson, I.A.
Deposit date:	2022-06-24
Release date:	2023-01-25
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (1.89 Å)
Cite:	Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity, 56, 2023

8DGX

Crystal structure of MERS-CoV spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC68.109 isolated from a vaccinated COVID-19 convalescent
Descriptor:	Antibody CC68.109 Fab heavy chain, Antibody CC68.109 Fab light chain, Spike protein S2'
Authors:	Liu, H, Wilson, I.A.
Deposit date:	2022-06-24
Release date:	2023-01-25
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (2.89 Å)
Cite:	Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity, 56, 2023

7RU1

SARS-CoV-2-6P-Mut7 S protein (C3 symmetry)
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Spike glycoprotein
Authors:	Ozorowski, G, Turner, H.L, Ward, A.B.
Deposit date:	2021-08-16
Release date:	2022-08-24
Last modified:	2024-01-17
Method:	ELECTRON MICROSCOPY (2.8 Å)
Cite:	Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways. Iscience, 25, 2022

7RU2

SARS-CoV-2-6P-Mut7 S protein (asymmetric)
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Spike glycoprotein
Authors:	Ozorowski, G, Turner, H.L, Ward, A.B.
Deposit date:	2021-08-16
Release date:	2022-08-24
Last modified:	2024-01-17
Method:	ELECTRON MICROSCOPY (3 Å)
Cite:	Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways. Iscience, 25, 2022

7RU4

CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement)
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, CC6.33 IgG heavy chain Fv, ...
Authors:	Ozorowski, G, Turner, H.L, Ward, A.B.
Deposit date:	2021-08-16
Release date:	2022-08-24
Last modified:	2022-09-14
Method:	ELECTRON MICROSCOPY (3.3 Å)
Cite:	Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways. Iscience, 25, 2022

7RU3

CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ...
Authors:	Ozorowski, G, Turner, H.L, Ward, A.B.
Deposit date:	2021-08-16
Release date:	2022-08-24
Last modified:	2022-09-14
Method:	ELECTRON MICROSCOPY (3.3 Å)
Cite:	Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways. Iscience, 25, 2022

7RU5

CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, CC6.30 Fab heavy chain Fv, ...
Authors:	Ozorowski, G, Turner, H.L, Ward, A.B.
Deposit date:	2021-08-16
Release date:	2022-08-24
Last modified:	2024-01-17
Method:	ELECTRON MICROSCOPY (3.6 Å)
Cite:	Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways. Iscience, 25, 2022

7RU8

CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement)
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, CC6.30 Fab Kappa chain Fv, ...
Authors:	Ozorowski, G, Turner, H.L, Ward, A.B.
Deposit date:	2021-08-16
Release date:	2022-08-24
Last modified:	2022-09-14
Method:	ELECTRON MICROSCOPY (3.8 Å)
Cite:	Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways. Iscience, 25, 2022

<123 4 5 >

Total results:	105
Displayed results:	25
Sorted by:	Hit score (from highest)